How donor & patient age can both impact outcomes

On-demand panel discussion link

Description

There are long-held perceptions that older patients are not suitable for transplantation. On the flip side, research shows that older donors may be associated with lower overall survival for patients. In this session, you will learn how age impacts patient outcomes—when it may be appropriate to consider older patients for HCT and why you should leverage younger donors. New data showing the advantage for HCT over non-HCT therapies in older MDS patients is also shared.

Learning Objectives

• The latest research in donor selection when weighing options between haplo, matched unrelated, and matched related donors
• Expanding MDS management to include HCT for fit older patients with high-risk MDS

Target Audience

Coordinators, physicians, medical directors

Speakers

• Jason Dehn, MPH, Director, Vendor and Biorepository Services, NMDP
• Nadit Khera, MD, Mayo Clinic Arizona
• Tien Le, Product Manager, NMDP